Viyash Scientific acquires Italy’s BioForLife
City-based Viyash Scientific Limited, through its wholly owned subsidiary Alivira Animal Health Limited, has signed an agreement to acquire 100 per cent stake in Italy-based BioForLife, a pet care company.
The Rs 188 crore acquisition is expected to close in Q2 FY27, Viyash Scientific Limited said in a release here on Monday. The transaction represents a significant step in Viyash’s strategy to capitalise on the mega-trend of a growing Companion Animal Health Generics market, it said. It expands Alivira’s global Companion Animal Health business and strengthens its presence in the European pet care market.
BioforLife (BFL), based in Milan, Italy, specialises in the development, commercialisation, and distribution of pet care products.
The acquisition will provide Viyash Scientific Limited, a platform for launching new products from Alivira’s pipeline in Italy, while simultaneously providing opportunities to expand the BFL range to other markets in the Alivira group located in Europe, the Middle East, Asia and Latin America.
Commenting on the acquisition, Viyash Scientific Limited Managing Director and Group CEO Haribabu Bodeputi said: “This acquisition represents another important step in our strategy to build a leading global Companion Animal Health business. BioForLife provides us with an established platform in Italy, one of Europe’s most attractive pet care markets, while strengthening our presence across the region”.
This transaction also strengthens the Alivira team with the induction of BFL executives who will continue to run the business operations, in addition to driving new growth initiatives, the release added.
